PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Cell. Author manuscript; available in PMC 2014 February 6.
Published in final edited form as:
PMCID: PMC3915719
NIHMSID: NIHMS544488

Autophagy Shows Its Animal Side

Abstract

Most autophagy genes have been discovered in the single-celled yeast Saccharomyces cerevisiae, and little is known about autophagy genes that are specific to multicellular animals. In this issue, Tian et al. (2010) now identify four new autophagy genes: one specific to the nematode Caenorhabditis elegans and three conserved from worms to mammals.

Autophagy, or “self-eating,” is a catabolic process that degrades and recycles cytoplasmic contents. Pioneering studies in the single-celled yeast Saccharomyces cerevisiae identified a suite of autophagy (Atg) genes required for survival during starvation (Mizushima, 2007). Although many of these genes are functionally conserved from yeast to mammals, autophagy is probably more complex in multicellular animals and most likely requires factors that are absent in yeast. For example, animal tissues maintain homeostasis when nutrients are locally restricted by trading off metabolic and catabolic processes, and this may be one reason that cancer cells with altered metabolism display elevated levels of autophagy (Mathew et al., 2007). However, little is known about autophagy machinery specific to animals. Now in a tour de force study, Tian et al. (2010) identify four previously uncharacterized genes specifically required for autophagy in multicellular animals and establish Caenorhabditis elegans as one of the premier genetic models for uncovering new autophagy genes in animals.

During autophagy, cytoplasmic contents, such as proteins and organelles, are engulfed by a double-membrane autophagosome (Figure 1), which then fuses with lysosomes to form autolysosomes. Here hydrolase enzymes degrade the cargo, and the products are subsequently released into the cytosol for reuse (Mizushima, 2007). Besides recycling cytoplasmic material during periods of starvation or stress, autophagy (also called macroautophagy) clears protein aggregates, eliminates pathogens, and influences cell death. Moreover, in many organisms, autophagy defects are associated with decreased life span, neurodegeneration, and tumor progression (Mizushima et al., 2008).

Figure 1
Genes Required for Autophagy in Animals

In worms (C. elegans), flies, and mammals, autophagy is also important during development (Meléndez and Neufeld, 2008). In C. elegans, germ cells contain aggregates of protein and RNA known as P granules, which are absent in somatic cells. A previous study demonstrated that autophagy is required for clearing the aggregate-prone components of P granules from somatic cells in developing C. elegans embryos (Zhang et al., 2009), and defects in autophagy lead to the aberrant accumulation of aggregates of P granule proteins in somatic cells.

Now Tian et al. (2010) use the persistence of P granule proteins in somatic cells to find mutant C. elegans embryos with defects in autophagy. From the ~160 mutants identified, the authors isolated four new genes, named epg-2, -3, -4, and -5 (ectopic PGL granules), which do not map to known autophagy genes. The coiled-coil protein, epg-2, mediates recognition of cargo (e.g., aggregates of P granule proteins) for delivery to autophagosomes and appears to be specific to nematodes. The other three genes, epg-3, -4, and -5, are also required for starvation-induced autophagy. They are conserved genetically from worms to mammals and appear to lack homologs in yeast.

In addition, the authors isolated numerous new mutations in genes homologous to yeast autophagy genes, which validate and strengthen the results of the study. Not only do these new mutations provide a valuable resource for probing the structure and function of autophagy proteins, but they also establish C. elegans as a preeminent system for studying the role and regulation of autophagy in multicellular animals.

Tian and colleagues found that EPG-3 is similar in sequence and function to the human vacuolar membrane protein 1, VMP1. Expression of human VMP1 remarkably rescues the P granule degradation defect in worm embryos with mutations in epg-3, and VMP1 is required for autophagy during starvation. In yeast, autophagosomes form at a specific cellular location called the pre-autophagosomal structure. Mammalian cells do not contain a clearly defined pre-autophagosomal structure. Instead, autophagosomes form from cup-shaped membrane fragments, called isolation membranes, which nucleate at multiple sites in the cytosol, including endoplasmic reticulum (ER)-derived structures termed omegasomes (Figure 1) (Axe et al., 2008). Defects in epg-3 or VMP1 lead to the accumulation of omegasomes in C. elegans embryos or rat kidney cells, respectively. Thus, although the exact roles of EPG-3 and VMP1 remain unknown, both proteins must function at an early step in autophagy. Perhaps EPG-3 and VMP1 facilitate the elongation of the isolation membrane or the closure of the double-membrane vesicle during autophagosome assembly (Figure 1).

Isolation membranes and omegasomes also accumulate in embryos with mutations in epg-4. Consequently, EPG-4 probably also functions in an early step of autophagosome formation. EPG-4 localizes to the ER, suggesting that it helps to convert ER membranes to autophagic membranes. In contrast, reducing the expression of EI24, the mammalian homolog of epg-4, does not affect omegasome formation in mammalian cells but instead results in the accumulation of autolysosomes that fail to degrade their contents. This suggests that EI24 functions later in the autophagy pathway than epg-4. The apparent phenotypic differences between defects in epg-4 and EI24 may be due to inefficient silencing of EI24, or these homologs may have diverged functionally during evolution.

Mutations in epg-5 lead to the persistent colocalization of P granule aggregates with protein markers known to associate with autophagosomes (Figure 1). Thus, although protein aggregates are near the autophagic machinery in these mutant embryos, the aggregates are probably not properly degraded. Mutations in other autophagy genes (i.e., atg-3, atg-13, or atg-5) suppressed the epg-5 phenotype, and these epistasis analyses suggest that epg-5 acts downstream of genes that regulate autophagosome formation.

As with EI24, silencing the epg-5 mammalian homolog mEPG-5 led to the persistence of autolysosomes that fail to degrade their contents. Transmission electron microscopy images revealed significant differences in the ultrastructures of the autolysomes present in embryos with reduced levels of EI24 and mEPG-5. Thus, future studies are needed to determine if these genes function in different steps in the degradation of autophagosome cargo.

In this landmark study, Tian et al. define discrete steps in the autophagy pathway that are specific to multicellular animals. Defects in autophagy are associated with numerous pathological conditions, including aging, neurodegeneration, and cancer (Mizushima et al., 2008). Therefore, it is interesting that the mammalian homologs of EPG-3, -4, and -5 are all associated with either human diseases or models of human disease. VMP1 is highly expressed in the pancreas of rats with acute pancreatitis (Dusetti et al., 2002), and it will be interesting to determine if VMP1 specifically functions in autophagy in the pancreas. EI24 expression is activated by tumor suppressor p53 and by etoposide, a chemotherapy drug that activates p53 (Gu et al., 2000). It could be that EI24 functions in a p53-independent or -dependent process. Notably, mEPG-5 is altered in human breast tumors (Sjöblom et al., 2006). Therefore, EI24 and mEPG5 may specifically regulate autophagy in cancer cells. The identification of these new genes by Tian et al. (2010) highlights the importance of autophagy in human diseases and may lead to exciting new discoveries about the role of autophagy in cancer and other disorders.

Acknowledgments

Our work on autophagy is supported by the NIH (GM079431).

Notes

This is a commentary on article Tian Y, Li Z, Hu W, Ren H, Tian E, Zhao Y, Lu Q, Huang X, Yang P, Li X, Wang X, Kovács AL, Yu L, Zhang H. C. elegans screen identifies autophagy genes specific to multicellular organisms. Cell. 2010;141(6):1042-55.

References

  • Axe EL, Walker SA, Manifava M, Chandra P, Roderick HL, Habermann A, Griffiths G, Ktistakis NT. J Cell Biol. 2008;182:685–701. [PMC free article] [PubMed]
  • Dusetti NJ, Jiang Y, Vaccaro MI, Tomasini R, Azizi Samir A, Calvo EL, Ropolo A, Fiedler F, Mallo GV, Dagorn JC, et al. Biochem. Biophys Res Commun. 2002;290:641–649. [PubMed]
  • Gu Z, Flemington C, Chittenden T, Zambetti GP. Mol. Cell Biol. 2000;20:233–241. [PMC free article] [PubMed]
  • Mathew R, Karantza-Wadsworth V, White E. Nat. Rev Cancer. 2007;7:961–967. [PMC free article] [PubMed]
  • Meléndez A, Neufeld TP. Development. 2008;135:2347–2360. [PMC free article] [PubMed]
  • Mizushima N. Genes Dev. 2007;21:2861–2873. [PubMed]
  • Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Nature. 2008;451:1069–1075. [PMC free article] [PubMed]
  • Sjöblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, et al. Science. 2006;314:268–274. [PubMed]
  • Tian Y, Li Z, Hu W, Ren H, Tian E, Zhao Y, Lu Q, Huang X, Yang P, Li X, et al. Cell. 2010 this issue.
  • Zhang Y, Yan L, Zhou Z, Yang P, Tian E, Zhang K, Zhao Y, Li Z, Song B, Han J, et al. Cell. 2009;136:308–321. [PubMed]